Jim Cramer’s ‘Mad Money’ Recap: This Stock Market Is No Bargain

Jim Cramer’s ‘Mad Money’ Recap: This Stock Market Is No BargainByScott RuttFollow|08/06/15 – 08:12 PM EDTSearch Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.NEW YORK (TheStreet) — Not every falling stock is a bargain, Jim Cramer warned his Mad Money viewers Thursday. Some are falling knives that will only lead to bright red losses.Cramer explained […]

Time to ring the register on this hot biotech play –

NPS CEO: Shire has rare-disease experience
NPS Pharmaceuticals president and CEO Dr. Francois Nader discusses opportunities the potential deal with Shire presents.
Anyone who follows Jim Cramer’s stock picks knows that he loves the biotech sector. Especially NPS Pharmaceuticals, up 45 percent in the past month. Wowzer!On Sunday, Ireland-based Shire PLC agreed to acquire NPS Pharma for an all cash deal of […]

Cramer's biotech bonanza: A zone free from oil pain

Cramer: Celgene has phenomenal pipeline
Mad Money’s Jim Cramer highlights winning biotech names out of the American Society of Hematology Annual Meeting.
As the market licks its wounds from the hideous decline in oil prices, Jim Cramer would like to remind investors that there is one leg of the industry that has no economic sensitivity whatsoever to the price of oil: biotechs. […]